Skip to main content
ABION Inc. logo

ABION Inc. — Investor Relations & Filings

Ticker · 203400 ISIN · KR7203400007 KO Professional, scientific and technical activities
Open in API
Filings indexed 408 across all filing types
Latest filing 2025-08-20 Major Shareholding Noti…
Country KR South Korea
Listing KO 203400

About ABION Inc.

https://abionbio.com/en/

ABION Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative medicines, focusing on first-in-class and best-in-class therapeutics for oncology and viral diseases. The company's lead oncology asset is ABN401, a selective c-Met tyrosine kinase inhibitor (TKI) designed to treat non-small cell lung cancer (NSCLC) with MET mutations, which has shown a favorable safety profile. Another key pipeline candidate is ABN501, a novel monoclonal antibody targeting Claudin-3 for various cancers. Beyond oncology, ABION is developing ABN101, a second-generation Interferon-β formulated as a broad-spectrum anti-viral inhaler for respiratory infections. The company aims to commercialize its assets in global markets through internationally recognized clinical processes.

Recent filings

Filing Released Lang Actions
최대주주변경을수반하는주식담보제공계약해제ㆍ취소등
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing from the Korean Exchange (KRX) regarding the cancellation of a stock collateral agreement that previously involved a potential change in the largest shareholder. This type of disclosure, which details changes in collateral status and financing arrangements, falls under the category of general regulatory announcements for corporate events that do not fit into specific financial reporting categories like 10-K or ER. Therefore, it is classified as a Regulatory Filing (RNS).
2025-08-20 Korean
[기재정정]사업보고서 (2024.12)
Annual Report Classification · 95% confidence The document is a 'Correction Report' (정정신고) for a previously filed 'Business Report' (사업보고서), which is the Korean equivalent of a 10-K. It contains detailed financial data, business operations, research and development activities, and contract information. Since it is a formal amendment to an annual report containing substantive financial and operational disclosures, it is classified as a 10-K. FY 2024
2025-08-14 Korean
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for the company '에이비온 주식회사' (ABION Inc.) covering the period from 2025.01.01 to 2025.06.30. It contains detailed financial information, business operations, management discussions, and corporate governance details, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2025
2025-08-14 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details changes in share ownership by Sangsangin Savings Bank and its affiliate in the company Abion Co., Ltd. This type of filing is specifically categorized as a Major Shareholding Notification (MRQ) in the provided schema.
2025-08-11 Korean
[기재정정]주주총회소집결의 (임시주주총회)
AGM Information Classification · 98% confidence The document is a formal notice of an Extraordinary General Meeting (EGM) and a correction filing regarding the agenda items (specifically the appointment of directors). In the context of corporate filings, documents detailing the solicitation of votes, meeting agendas, and director appointment proposals for shareholders are classified as Proxy Solicitation & Information Statements (PSI).
2025-08-07 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of Extraordinary General Meeting of Shareholders' (제19기 임시주주총회 소집공고) issued by Abion Inc. It contains the meeting agenda, details on director appointments, and management reference materials. This document is a standard proxy solicitation material sent to shareholders to inform them of the meeting and request their votes, which falls under the 'Proxy Solicitation & Information Statement' category.
2025-08-07 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.